Neuphoria Therapeutics Inc. (NEUP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Neuphoria Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -20.37x | -53.48x | -224.01x | -412.44x | -1770.95x | -1688.37x |
| P/B Ratio | 0.40x | 70.92x | 330.97x | 241.63x | 428.20x | 1334.09x |
| P/S Ratio | 0.48x | 0.00x | 0.00x | 34041.66x | 0.00x | 257574.47x |
| Profitability | ||||||
| Gross Margin | 95.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -7.2% | 0.0% | 0.0% | -10292.0% | 0.0% | -25865.5% |
| Net Margin | -2.4% | 0.0% | 0.0% | -8253.6% | 0.0% | -15255.8% |
| EBITDA Margin | -1.1% | 0.0% | 0.0% | -10085.7% | 0.0% | -10035.1% |
| Liquidity | ||||||
| Current Ratio | 3.56x | 3.45x | 4.87x | 12.46x | 13.10x | 1.01x |
| Quick Ratio | 3.56x | 3.45x | 4.87x | 12.46x | 13.10x | 1.01x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.02x | 0.02x | 0.01x | 0.02x | 0.96x |
YoY = year-over-year change. Source: FMP..